Loading…

compare compounds

class, effects, and the receptor fingerprint, side by side; add up to four, then source the whole stack

reading the marksactivatesblocks / inhibitsmodulates

39CB

CBD

Cannabinoid

Serotonin 5-HT1Aagonist

moderateEC50 ~8 µM

FAAH (anandamide)inhibits

moderateIC50 ~28 µM

TRPV1agonist

moderateEC50 ~3 µM

CB1 / CB2negative allosteric / weak

weakKi ~230-1265 nM

39CB

CannabinoidPhytocannabinoidAnalgesic

effects: Endocannabinoid System, TRP Channels, CB2 Receptor, Anandamide, Adenosine, Mood, Inflammation
suppliers: reference only

TRPA1 channelAgonist / desensitizer

strongEC50 ~90 nM

Anandamide cellular uptakeInhibits

moderate

CB2 receptorPartial agonist

weakKi ~260 nM

CB1 receptorWeak binder

weakKi ~710 nM

NAAA enzymeInhibits (botanical preparation)

weak

Adenosine A1 receptorModulates (indirect, via adenosine/ATP)

moderate

ERK1/2 (MAPK)Activates phosphorylation

moderate

Add compound

no matches for “”

OverallNo data

checking CBD and Cannabichromene: no notable interaction flagged; they read as broadly independent.

CBD + Cannabichromene
No data
no notable interaction flagged; these look broadly independent.

General educational info, not medical advice.